“We think it’s a pathway to a new approach to get long-term remission, and then ultimately a cure,” he said. “We’re not there yet, but we think we’re getting such encouraging results.” Changes to CAR ...

The adaptive, biomarker-directed trial allows researchers to enrich for best responders and open new sub-studies for non-responders based on emerging data.

The well-studied NF-κB signaling system is a key mediator of the inflammatory response. Large-scale sequencing studies in ...

Cancer plasticity allows tumor cells to change their identity, evade therapies, and adapt to environmental pressures, contributing to treatment resistance and metastasis. New research is targeting ...

ASCO Annual Meeting highlighted key advances in brain cancer and brain metastases for patients affected by the disease.

Glioblastoma has been deadly and hard to treat, but researchers say they’ve made progress with bivalent CAR T-cell therapy ...

India faces a steady rise in brain tumor cases. Experts urge immediate action to boost awareness, early diagnosis, and access to affordable treatment.

Don't miss the warning signs! Expert sheds light on why early symptoms of brain tumours in children are often ignored. Learn ...

The very mention of brain tumour tends to stop you in your tracks . And of all brain tumours, there is one that is especially ...

Glioblastoma (GBM) is the most aggressive and lethal form of brain cancer, with a median survival of only 15 months despite ...

The lack of response of glioblastoma (GBM) to immunotherapy is closely related to the limited number of T cells in the tumor microenvironment. However, it is still not known why GBM is characterized ...